By using innovative, patient-derived organoid models to replicate human organs in the lab, Dr. Mike Oliphant and his team aim to develop targeted therapies that strip cancer cells of their resilience. Learn more about this groundbreaking research in breast cancer at bit.ly/4u5IFa6. 🎗️🩷
